Physician

David Andrew Riseberg, MD

According to 2025 Medicare claims, David Riseberg, MD (NPI: 1124133210) practices medical oncology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Baltimore, MD. This provider's primary affiliated billing organization is LUTHERVILLE HEMATOLOGY AND ONCOLOGY SERVICES (NPI: 1538454228; TIN: 27-4697590) and primary practice location at 21093-5606.

Riseberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,045 traditional Medicare patients, billed 93,280 HCPCS/CPT codes, and received $1,505,756 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,401 prescription claims across 412 beneficiaries totaling $1,712,828 in drug costs, led by Ibrance (Palbociclib). DME data shows 82 claims. Open Payments data shows 182 records totaling $580,200. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $109,406 to $1,505,756. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $410,165 and ending at $1,712,828. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $17,616 to $13,930.